NCT01236807

Brief Summary

The purpose of this study is to determine if MR Perfusion Imaging is non-inferior to coronary angiography with measurement of Fractional Flow Reserve (FFR) in guiding management of patients with stable chest pain.

  • All patients will undergo an MR Perfusion Imaging test.
  • Further management will be guided by the result of the cardiac MRI in half of the patients (chosen by random).
  • The other half will undergo coronary angiography with measurement of FFR. The result of this test alone will guide their further management. The result of the initial MR Perfusion test will not be available to the treating doctors of this group.
  • All patients will receive optimal medical therapy (OMT)
  • All patients will undergo follow-up to find out if they have any relevant heart related events.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
915

participants targeted

Target at P75+ for not_applicable coronary-artery-disease

Timeline
Completed

Started Dec 2010

Longer than P75 for not_applicable coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 8, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 9, 2010

Completed
22 days until next milestone

Study Start

First participant enrolled

December 1, 2010

Completed
5.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

June 24, 2022

Status Verified

June 1, 2022

Enrollment Period

5.7 years

First QC Date

November 8, 2010

Last Update Submit

June 21, 2022

Conditions

Keywords

AdenosineMagnetic Resonance ImagingMR perfusionFractional Flow Reserve, MyocardialFFRPressure wireCoronary DiseaseHeart DiseasesCardiovascular DiseasesArteriosclerosis

Outcome Measures

Primary Outcomes (1)

  • Occurence of major adverse cardiac events (MACE)

    Composite of all cause death, myocardial infarction and repeat revascularisation.

    1year

Secondary Outcomes (5)

  • Individual MACE

    1 year

  • Other adverse events

    1 year

  • Course of symptoms (angina, breathlessness)

    1 year

  • Cost comparison

    1 year

  • changes in LV volumes and function

    1 year

Study Arms (2)

MR Inform

ACTIVE COMPARATOR

Management guided by the result of the MR perfusion scan. Possible intervention: coronary artery revascularization.

Procedure: MR perfusion guidance

FFR Inform

ACTIVE COMPARATOR

Management guided by the result of FFR measurement. Possible intervention: coronary artery revascularization.

Procedure: FFR guidance

Interventions

Coronary revascularization guided by MR perfusion imaging

MR Inform
FFR guidancePROCEDURE

Coronary revascularization guided by invasive angiography and FFR

FFR Inform

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Angina pectoris CCS class II and III and either
  • ≥2 cardiovascular risk factors
  • or positive exercise treadmill test
  • Signed written informed consent
  • age: at least 18 years

You may not qualify if:

  • contraindication to MR
  • contraindication to adenosine infusion
  • EF≤ 30%
  • inability to lie supine for 60 minutes
  • previous Coronary Artery Bypass Grafts
  • revascularization within the previous 6 months
  • cardiac arrhythmias (atrial fibrillation, \>20 ectopic beats/min)
  • poor renal function (eGFR \<30ml/min)
  • body weight \> 140kg or waist perimeter \> 95cm
  • known allergy to contrast media

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

King's College

London, SE1 7EH, United Kingdom

Location

Related Publications (3)

  • Hussain ST, Paul M, Plein S, McCann GP, Shah AM, Marber MS, Chiribiri A, Morton G, Redwood S, MacCarthy P, Schuster A, Ishida M, Westwood MA, Perera D, Nagel E. Design and rationale of the MR-INFORM study: stress perfusion cardiovascular magnetic resonance imaging to guide the management of patients with stable coronary artery disease. J Cardiovasc Magn Reson. 2012 Sep 19;14(1):65. doi: 10.1186/1532-429X-14-65.

    PMID: 22992411BACKGROUND
  • Nagel E, Berry C. Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease. Reply. N Engl J Med. 2019 Dec 5;381(23):2277-2278. doi: 10.1056/NEJMc1913968. No abstract available.

    PMID: 31801003BACKGROUND
  • Nagel E, Greenwood JP, McCann GP, Bettencourt N, Shah AM, Hussain ST, Perera D, Plein S, Bucciarelli-Ducci C, Paul M, Westwood MA, Marber M, Richter WS, Puntmann VO, Schwenke C, Schulz-Menger J, Das R, Wong J, Hausenloy DJ, Steen H, Berry C; MR-INFORM Investigators. Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease. N Engl J Med. 2019 Jun 20;380(25):2418-2428. doi: 10.1056/NEJMoa1716734.

MeSH Terms

Conditions

Coronary Artery DiseaseAngina, StableCoronary DiseaseHeart DiseasesCardiovascular DiseasesArteriosclerosis

Condition Hierarchy (Ancestors)

Myocardial IschemiaArterial Occlusive DiseasesVascular DiseasesAngina PectorisChest PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Eike Nagel, MD, PhD

    Goethe University Frankfurt

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Global Chief Investigator

Study Record Dates

First Submitted

November 8, 2010

First Posted

November 9, 2010

Study Start

December 1, 2010

Primary Completion

August 1, 2016

Study Completion

December 1, 2016

Last Updated

June 24, 2022

Record last verified: 2022-06

Locations